Form 4 for CVS CVS Health
Accepted 2024-12-03 00:00:00 ET · period of report 2024-11-30 · accession 0001127602-24-028486 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-03 | 2024-11-30 | CVS | Mandadi Tilak | EVP, Chief DDAT Off | A - Grant | $59.85 | +50.1K | 99.7K | +101% | +$3.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (RSU) | 2024-11-30 | A | A | 50,125 | $59.85 | 99,747 | D | — | — |